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The knowledge regarding the intestinal microbial types involved in isoflavone
bioavailability and metabolism is still limited. The present work reports the influence
of a treatment with isoflavones for 6 months on the fecal bacterial communities of
16 menopausal women, as determined by culturing and culture-independent microbial
techniques. Changes in fecal communities were analyzed with respect to the women’s
equol-producing phenotype. Compared to baseline, at 1 and 3 months the counts for
all microbial populations in the feces of equol-producing women had increased strongly.
In contrast, among the non-producers, the counts for all microbial populations at 1
month were similar to those at baseline, and decreased significantly by 3 and 6 months.
Following isoflavone intake, major bands in the denaturing gradient gel electrophoresis
(DGGE) profiles appeared and disappeared, suggesting important changes in majority
populations. In some women, increases were seen in the intensity of specific DGGE
bands corresponding to microorganisms known to be involved in the metabolism
of dietary phytoestrogens (Lactonifactor longoviformis, Faecalibacterium prausnitzii,
Bifidobacterium sp., Ruminococcus sp.). Real-Time quantitative PCR revealed that
the Clostridium leptum and C. coccoides populations increased in equol producers,
while those of bifidobacteria and enterobacteria decreased, and vice versa in the non-
producers. Finally, the Atopobium population increased in both groups, but especially in
the non-producers at three months. As the main findings of this study, (i) variations in
the microbial communities over the 6-month period of isoflavone supplementation were
large; (ii) no changes in the fecal microbial populations that were convincingly treatment-
specific were seen; and (iii) the production of equol did not appear to be associated with
the presence of, or increase in the population of, any of the majority bacterial types
analyzed.
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Introduction
Compared to Caucasian women, fewer Asian women suﬀer
discomfort during menopause. They also have better intestinal
health, and enjoy lower rates of cardiovascular disease (Bhupathy
et al., 2010) and cancer (Virk-Baker et al., 2010). The better
health of these women has been associated with a higher intake
of soy foods (Messina, 2000). Soy contains many biologically
active compounds (Kang et al., 2010), but its beneﬁcial health
eﬀects have been attributed to its isoﬂavone content (Sánchez-
Calvo et al., 2013). At the molecular level, the health beneﬁts of
dietary isoﬂavones appear to bemediated through their hormonal
(Yuan et al., 2007), antioxidant (Wang et al., 2008), and enzyme-
inhibitory (Crozier et al., 2009) activities.
In nature, isoﬂavones (daidzin, genistin, glycitin) mostly
(>80%) appear conjugated with sugars as isoﬂavone-glycosides,
the bioavailability and bioactivity of which are low (Crozier
et al., 2009; de Cremoux et al., 2010). For their full activity
to be realized, aglycones (daidzein, genistein, glycitein) need to
be released from these isoﬂavone-glycosides and, occasionally,
metabolized (Sánchez-Calvo et al., 2013). The transformations
necessary are mostly performed by the enzymes of the gut
microbiota. However, though improving, our knowledge of the
gut microbes, their enzymes, and the pathways involved in
the metabolism of isoﬂavones, is still limited (Atkinson et al.,
2005; Yuan et al., 2007; Kemperman et al., 2010; Clavel and
Mapesa, 2013). The metabolism of isoﬂavones is thought to occur
in sequential steps involving several enzymes produced by a
number of microbial types (Clavel and Mapesa, 2013; Sánchez-
Calvo et al., 2013). The release of aglycones from conjugated
isoﬂavones starts via the action of the widely distributed glycosyl
hydrolases (members of the β-glucosidase family; Cantarel et al.,
2009). The aglycones formed then undergo dehydroxylation,
reduction, the breakage of the pyrone ring, and demethylation,
etc., giving rise to compounds either of greater biological activity
(such as equol and 5-hydroxy equol) or inactive molecules [such
as o-demethylangolensin (O-DMA); Clavel and Mapesa, 2013].
Due to the inter-individual diversity in microbiota composition
(Frankenfeld, 2011), only around 30–50% of Western women
are capable of producing equol, while around 80–90% produce
O-DMA. It may be that equol-producing women beneﬁt more
fully from the intake of isoﬂavones (Sánchez-Calvo et al.,
2013).
Like other polyphenols, isoﬂavones have antimicrobial
activity, which can modulate the diversity and composition of
the gut microbiota after their consumption (Kemperman et al.,
2010). The inhibition of pathogens or an increase in the size
of beneﬁcial populations might then contribute toward health
beneﬁts. However, studies on how isoﬂavones inﬂuence the
composition and activity of the gut microbial community, and its
eﬀect on human health, are scarce (Clavel et al., 2005; Bolca et al.,
2007; Nakatsu et al., 2014). Further, the results of the studies that
are available are hard to compare, a consequence of diﬀerences in
treatment regimen, target group, and the techniques employed.
However, understanding how microorganisms and metabolites
interact and elicit a physiological response (or lack thereof) is
crucial if the results of observational and interventional studies
are to be properly interpreted. Investigations that assess in vivo
the response of gut populations to isoﬂavone consumption are
much needed.
The main aim of the present study was to determine the
eﬀect of long-term dietary supplementation with an isoﬂavone
concentrate on the fecal microbial communities of menopausal
women, via both culturing and culture-independent techniques.
Women were entering a treatment of menopause symptoms with
an isoﬂavone concentrate, which made unnecessary the design of
an intervention study. The microbial results were correlated with
equol production status in an attempt to identify those microbial
populations and/or numbers linked to the production of this
active, microbial-derived compound.
Materials and Methods
Human Volunteers and Urine and Stool
Samples
This study was approved by the Research Ethics Committee of
the Principado de Asturias, Spain. The selection of donors and
later sampling was performed following standardized protocols
recommended by the above committee. Sixteen menopausal
women (age range 48–61; average 53.4) were recruited at the
Obstetrics and Gynaecology Service of the Hospital de Cabueñes
(Gijón, Spain). No participants suﬀered from any disease or
intestinal disorder. Additionally, they had received no treatment
with antibiotics or any other medication for at least 6 months
prior to the start of the study. All participants consumed one
tablet containing 80 mg of an isoﬂavone concentrate (Fisiogen;
Zambon, Bresso, Italy) per day for 6 months. Urine and fecal
samples were collected at four time points: before the start
of the treatment (t = 0), and at one (t = 1), three (t = 3),
and six (t = 6) months. Morning urine samples and freshly
voided stools were collected by the volunteers themselves, the
latter in sterile plastic containers, in which they were maintained
under anaerobic conditions via the use of Anaerocult A (Merck,
Darmstadt, Germany). All samples were a transported to the
laboratory by courier. Stool samples were subjected to microbial
analyses within 2 h of arrival; dilutions for culture-independent
techniques were kept frozen at –80◦C until use, as were urine
samples for later equol and creatinine analysis.
Determination of Equol and Creatinine in Urine
Samples
Three milliliters of thawed urine samples were diluted with 3 mL
of 0.1 M acetate buﬀer (pH 4.5) and treated for 20 h at 37◦C
with 10 μL of extract type H-1 crude enzyme solution from
Helix pomatia (Sigma–Aldrich, St. Louis, MO, USA). This has
β-glucuronidase (100 units/μL) and sulphatase (7.5 units/μL)
activities. Equol was extracted using Bond Elut-C18 200mg solid-
phase cartridges (Agilent Technologies, Santa Clara, CA, USA),
pre-conditioned with 3 mL of methanol and 3 mL of acetate
buﬀer 0.1 M pH 4.5. Treated urine was passed through the
cartridges, which were then washed with 3 mL acetate buﬀer
0.1 M (pH 4.5). To remove any residual water, 200 μL of ethyl
acetate were eluted through the cartridges and rejected; this
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roughly corresponded to the column dead volume. Equol was
then eluted with 1 mL of ethyl acetate, ﬁltered through a 0.2 μm
PTFE membrane, and then evaporated to dryness under vacuum
at room temperature. Prior to analysis, extracts were dissolved
in 100 μL methanol [high-performance liquid chromatography
(HPLC) grade) and kept at 4◦C in opaque vials with screw caps.
A 2mM stock solution of equol (Sigma–Aldrich) inmethanol was
used to prepare a calibration curve covering six concentrations
from 0.005 to 363.60 μM.
Equol in urine was determined using an H-Class Acquity
UPLCTM ultra-high-performance liquid chromatography
(UHPLC) system (Waters) equipped with a BEH reversed-phase
C18 chromatographic column (1.7 μm, 2.1 mm × 100 mm;
Waters, Palo Alto, CA, USA; Redruello et al., unpublished).
The temperature of the column was set at 40◦C. The mobile
phase consisted of H2O supplemented with 0.05% phosphoric
acid (solvent A) and 100% methanol (solvent B). Samples were
applied onto the column and eluted at a ﬂow rate of 0.45 mL/min
according to the following linear gradient: 0 min 90% A/10% B;
1 min 88% A/12% B; 3.5 min 75% A/25% B; 6.5 min 75% A/25%
B; 10 min 50% A/50% B; 12 min 10% A/90% B; and 16 min
10% A/90% B. This was followed by washing with 10%A/90% B
for 4 min and then 5 min with 90% A/10% B to re-equilibrate
the column. Equol was measured using a ﬂuorescence detector
(excitation 280 nm, emission 310 nm).
As a single urine sample was analyzed, creatinine was
determined to normalize equol excretion values. Equol was
measured using a kinetic-photometric method based on the
Jaﬀe reaction (Heinegård and Tiderström, 1973). For this,
urine was treated with an alkaline picrate solution resulting
in a bright orange–red complex. The formation rate of the
complex over a preﬁxed interval of time (measured as an
increase in absorbance) is proportional to the concentration
of creatinine in the sample. Reactions were performed in 96-
well microplates and measurements made using a Benchmark
Plus microplate spectrophotometer (Bio-Rad, Richmond, CA,
USA). Two hundred microliters of 10-fold diluted urine were
added to a 2 mL solution of 25 mM picric acid prepared in
300 mM phosphate buﬀer (pH 12.1) containing 2 g/L SDS (to
avoid protein precipitation). The reaction was allowed to proceed
at 37◦C and mixed every 5 s. The absorbance at 510 nm was
measured over 6 min and the reaction rate determined as the
tangent in the linear part of the kinetic curve between 0.08 and
5 min. Each sample was assayed in triplicate.
Fecal Microbiota Analyses
Microbial Counts
All fecal samples were processed in a Mac500 anaerobic chamber
(Down Whitley Scientiﬁc, West Yorkshire, UK) containing a
10% H2, 10% CO2, 80% N2 atmosphere. For microbial analyses,
1 g of feces was homogenized in 9 mL of sterile Maximum
Recovery Diluent (Scharlab, Barcelona, Spain). The homogenates
were then serially diluted and plated in duplicate onto general and
selective agar media. Total and indicator bacterial populations
were counted using the media as follows: for lactobacilli,
de Man-Rogosa-Sharpe agar (Scharlab) supplemented with
0.25% cysteine (VWR International, Radnor, PA, USA; MRSC);
for clostridia, agariﬁed Reinforced Clostridial Medium (RCM;
Merck, Darmstadt, Germany); for Bifidobacterium sp., modiﬁed
Columbia agar (BCCMTM/LMG, Medium M144; BIF; Masco
et al., 2003); for Enterobacteriaceae, Eosin Methylene Blue agar
(EMB; Oxoid, Basingstoke Hampshire, UK); for Veillonella sp.,
Veillonella agar (VA; Merck); for Bacteroides and Prevotella (BP),
specialized Bacteroides and Prevotella agar (Ly et al., 2007); and
for total microorganisms, Medium for Colon Bacteria (MCB;Van
der Meulen et al., 2006). Counting was performed after anaerobic
incubation of the plates at 37◦C for 72 h, with the exception of
the EMB plates, for which enumeration analysis was performed
after aerobic incubation for 24 h. Data were recorded as colony
forming units (cfu)/g of feces, were transformed to logarithmic
units before statistical analysis.
DNA Extraction from fecal Samples
Extraction of total bacterial DNA was based on the method of
Zoetendal et al. (2006) using the QIAamp DNA Stool Minikit
(Qiagen, Hilden, Germany) with some modiﬁcations of the
manufacturer’s protocol. Brieﬂy, 0.2 g of thawed fecal samples
were suspended in 1.8 mL of phosphate buﬀer saline solution
(PBS; pH 7.4). The fecal suspension was homogenized by
vortexing and centrifuged at 800 rpm at 4◦C for 10 min to
eliminate insoluble materials. Supernatants were transferred to
new tubes and centrifuged at 14,000 rpm at 4◦C for 5 min.
Pellets were suspended in 200 μL of lysis solution (20 mM Tris-
HCl pH 8.0, 2 mM EDTA, 1.20% Triton X-100, and 20 mg/mL
lysozyme). Twenty units of mutanolysin (Merck, Darmstadt,
Germany) were added to the mixture, which was then incubated
at 37◦C for 40 min. Immediately after, 1.2 mL of the lysis buﬀer
from the DNA-isolation kit were added, the mixture placed in
a screw-cap tube containing 0.3 and 0.1 g of 0.1 and 0.5 mm
zirconia/silica beads, respectively, (BioSpec Products, Bartlesville,
OK, USA) and subjected to mechanical breakage in a FastPrep
FP120 Cell Disrupter (Qbiogene, Carlsbad, CA, USA; three cycles
at 5.5 m s−1 for 30 s, cooling the samples on ice between cycles).
Cell extracts were loaded onto the kit’s column following the
manufacturer’s recommendations. Finally, the DNA was eluted
with 150 μL sterile molecular biology grade water (Sigma–
Aldrich) and stored at –20◦C until required.
Denaturing Gradient Gel Electrophoresis (DGGE)
Amplification
The variable V3 region of the 16S rRNA gene was
ampliﬁed by PCR using the universal primers F357
(5′-TACGGGAGGCAGCAG-3′), to which a 39 bp GC
sequence was linked to give rise to GC-F357 and R518 (5′-
ATTACCGCGGCTGCTGG-3′), (Muyzer et al., 1993). The V2
and V4 regions were ampliﬁed with Bifidobacterium-speciﬁc
primers F-Bif164 (5′-GGGTGGTAATGCCGGATG-3′) and
R-Bif662 (5′-CCACCGTTACACCGGGAA-3′); a 40 bp GC
sequence was linked to the latter to give rise to R-Bif662-GC
(Satokari et al., 2001). Each reaction mixture consisted of 0.2 mM
of each deoxynucleoside triphosphate (dNTPs), 0.24 μM of each
forward and reverse primer, 2 U of 5 Prime Taq polymerase
(VWR International), and between 100 and 150 ng of puriﬁed
DNA. The PCR ampliﬁcation programs were as follows: for
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primers F357-GC and R518 – an initial denaturation step at
95◦C for 5 min, followed by 35 cycles of 95◦C for 30 s, 56◦C for
30 s, and 72◦C for 40 s, plus a ﬁnal extension step at 72◦C for
10 min; for primers F-Bif164 and R-Bif662-G – after an identical
denaturation step, 35 cycles of 95◦C for 30 s, 62◦C for 40 s, and
72◦C for 1 min, plus a ﬁnal extension step at 72◦C for 5 min.
DGGE Analysis
Denaturing gradient gel electrophoresis was undertaken in
a DCode apparatus (Bio-Rad) at 60◦C. Electrophoresis was
performed at 200 V for 10 min in an 8% polyacrylamide
stacking gel, followed by 75 V for 16 h in a denaturing gel
in 0.5X Tris-acetate-EDTA (TAE) buﬀer. The urea-formamide
denaturing ranges were 40–55% for amplicons obtained with
primers F357-GC/R518 and 45–55% for amplicons obtained with
primers F-Bif164/R-Bif662-GC. After staining in an ethidium
bromide solution, the gels were visualized under UV light
using a GBox system (Syngene, Cambridge, UK) equipped with
GeneSys image acquisition software (Syngene). Selected bands
were excised from the gels, suspended in sterile molecular grade
water, and kept overnight at 4◦C. Subsequently, the eluted DNA
was used as a template in new ampliﬁcation reactions involving
the same primers without the GC-clamp. Finally, amplicons
were puriﬁed using GenElute PCR Clean-Up columns (Sigma–
Aldrich) and sequenced using an ABI Prism gene sequencer
(Applied Biosystems, Foster City, CA, USA). Sequences were
compared using the Blast program1 and the Classiﬁer tool
provided by the Ribosomal Database Project2. Sequences with
a percentage nucleotide match of 97% or higher to those in
databases were assigned to the corresponding species.
The gels were digitalized and analyzed using Gene Tools v.4.03
software. For each DGGE proﬁle, the Shannon–Weaver diversity
index (H index) was estimated on the basis of the number
1http://www.ncbi.nlm.nih.gov/BLAST/
2http://rdp.cme.msu.edu/index.jsp
of bands (assuming them to be equivalent to the number of
species) and their relative intensity. Additionally, the similarity
between the DGGE proﬁles (presence or absence of bands
and their intensities) was determined by calculating the Dice’s
coeﬃcient. Clustering was performed using the unweighted pair
group method with arithmetic averages (UPGMA), employing
the DendroUPGMA computer program3.
Real-Time quantitative PCR (qPCR)
Quantiﬁcation of the diﬀerent bacterial populations in feces
was performed by qPCR using group-speciﬁc primers targeting
the 16S rRNA gene (Table 1). Ampliﬁcation reactions were
performed in 96-well optical plates (Applied Biosystems) in a
7500 Fast Real-Time PCR System (Applied Biosystems). All
ampliﬁcations were performed in triplicate in a ﬁnal volume of
25 μL containing 2x SYBR Green PCR Master Mix (Applied
Biosystems), 0.2 μM of each primer and 1 μL of template DNA
(5–10 ng). The thermal cycling protocol followed consisted of an
initial cycle at 95◦C for 10 min, followed by 40 cycles at 95◦C
for 15 s, and 1 min at the appropriate primer-pair annealing
temperature (Table 1). To check for speciﬁcity, melting curve
analysis was performed, increasing the temperature from 60
to 95◦C at a rate of 0.2◦C per second with the continuous
monitoring of ﬂuorescence. Primer eﬃciency was calculated
from the slope of the standard curve for each primer set
(E = 10−1/slope). The diﬀerent bacterial groups were expressed as
relative quantities (percentage of the total bacterial 16S rDNA in
the sample) according to Vigsnæs et al. (2011).
Statistical Analysis
Statistical analysis of the culturing and qPCR data was performed
using free R software4. The Shapiro–Wilk test was used to check
for the normal distribution of the data. As several variables did
3http://genomes.urv.es/UPGMA/
4http://www.r-project.org
TABLE 1 | Bacterial target groups and characteristics of primers used for quantitative PCR (qPCR) in this study.
Microbial target Primer Sequence 5′–3′ Annealing (◦C) Efficiencya Reference
Bifidobacterium sp. F-bifido
R-bifido
CGCGTCYGGTGTGAAAG
CCCCACATCCAGCATCCA
60 1.90 Delroisse et al. (2008)
Lactobacillus sp. Lacto-F
Lacto-R
AGCAGTAGGGAATCTTCCA
CACCGCTACACATGGAG
60 1.96 Heilig et al. (2002)
Clostridium coccoides group g-Ccoc-F
g-Ccoc-R
AAATGACGGTACCTGACTAA
CTTTGAGTTTCATTCTTGCGAA
60 1.93 Matsuki et al. (2004)
Clostridium leptum group g-Clept-F
g-Clept-R
GCACAAGCAGTGGAGT
CTTCCTCCGTTTTGTCAA
60 1.89 Matsuki et al. (2004)
Bacteroidetes phylum Bact934F
Bact1060R
GGARCATGTGGTTTAATTCGATGAT
AGCTGACGACAACCATGCAG
60 1.92 Guo et al. (2008)
Atopobium cluster c-Atopo-F
c-Atopo-R
GGGTTGAGAGACCGACC
CGGRGCTTCTTCTGCAGG
60 1.90 Matsuki et al. (2002)
Enterobacteriaceae En-lsu3F
En-lsu3-R
TGCCGTAACTTCGGGAGAAGGCA
TCAAGGCTCAATGTTCAGTGTC
55 1.97 Matsuda et al. (2007)
Total bacteriab TBA-F
TBA-R
CGGCAACGAGCGCAACCC
CCATTGTAGCACGTGTGTAGCC
60 1.93 Dennan and McSweeney (2006)
aPrimer efficiency was calculated from the slope of the standard curve for each primer set as E = 10−1/slope.
bTBA primers were used for quantification of total bacterial DNA. This value was used to normalize differences in DNA concentration between individual samples.
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not follow a normal distribution, comparisons were performed
by using non-parametric tests. The Mann–Whitney test for
independent samples was performed to examine diﬀerences
between equol producers and non-producers in terms of the
microbial groups studied at every sampling point. The Wilcoxon
signed-rank test for related samples was used to examine
diﬀerences within microbial groups at all sampling points for
both equol producers and non-producers. Two-tailed probability
values of P < 0.05 were considered signiﬁcant. Multivariate
statistics was performed by principal coordinates analysis (PCoA)
to search for associations between equol production status and
the microbial groups determined by culturing and qPCR.
Results
Urine Equol after Isoflavone Supplementation
To test whether changes in the fecal microbial communities were
associated with equol production phenotype, the equol status of
the women was assessed by determining the concentration of
this compound in their urine by UHPLC. Urine creatinine was
also determined to normalize the equol values. Equol-producing
women were deﬁned as those responding to the soy challenge by
showing an increase in urine equol to over 1000 nM (the cut-oﬀ
deﬁned by Rowland et al., 2000), and having an equol/creatinine
ratio of >5.
Similar (and low) equol concentrations and equol/creatinine
ratios were observed in the samples from all 16 women at
t = 0 (Table 2). However, at t = 1, 100-fold increments in the
ratios were obtained in the urine of four (25%) of the women
(WA, WC, WG, and WP; Supplementary Table S1). In these
subjects, the urinary excretion of equol at all post t = 0 sampling
points (with the exception of t = 3 in woman WA) reached
values above the stated cut-oﬀ. They were therefore considered
equol producers. However, large variations in absolute equol
concentrations were detected among their samples, as well as
diﬀerences between samples for the same individual subject at
diﬀerent times (Supplementary Figure S1). In general, maximum
equol production was observed at t = 1. After this point
TABLE 2 | Average equol production during isoflavone treatment in urine
samples among equol producer and non-producer women of this study.
Equol status Sample
(month)
Parameter
Equola Equol/Creatinine
Producers (n = 4) 0 59.50 0.58
1 18716.75 77.62
3 8114.00 38.13
6 5702.50 28.63
Non-producers (n = 12) 0 39.00 0.73
1 19.42 0.12
3 28.08 0.23
6 15.58 0.10
aConcentration of equol in nM.
production was either maintained (in WC and WP) or fell by
t = 3 and t = 6 (in WA and WG). Low equol levels, sometimes
close to the limit of detection and/or of the limit of quantiﬁcation,
were measured in most urine samples from the non-producer
women (Table 2).
Microbial Counts
Wide inter-individual and inter-sample variations in counts
for the diﬀerent microbial populations were recorded over the
supplementation period (Table 3). Although the response seemed
erratic, some general trends were appreciated for equol producers
and non-producers. At t = 0, counts for total and indicator
microbial populations were generally slightly higher in the feces
of the non-producers (Table 3). However, counts for all microbial
populations increased strongly at t = 1 and t = 3 in the feces of
the equol producers. In addition, in the equol producers, most
cultivable populations decreased by t= 6, showing a trend toward
the numbers recorded at t = 0. In contrast, in the non-producers,
the counts for all microbial populations at t = 1 were similar to
those at t = 0, but decreased signiﬁcantly by t = 3 and t = 6
(Table 3). However, at the personal level, most microbial groups
changed unpredictably in each of the women (Supplementary
Table S2).
Community Profiling by DGGE
The community proﬁles showed 12–22 distinct DGGE bands
of diﬀerent intensity (Figure 1). Proﬁles contained between
3 (WP samples) through 8 (WF, WH samples) bands of a
high intensity, being the rest of low or very low intensity.
The appearance and disappearance of intense bands in the
samples of individual subjects at consecutive sampling points
(see Figure 1, WD-1, WF-3, and WH-1) indicates major changes
in the majority bacterial populations. Since DGGE is a semi-
quantitative technique, increases and reductions in the intensity
of bands suggests corresponding changes in the fortune of the
associated species. In general, isoﬂavone supplementation led to
a reduction in the Shannon–Weaver diversity index (H index)
compared to t = 0. The UPGMAcomparison of Dice’s coeﬃcients
showed a clear clustering of the proﬁles by subject (with only two
exceptions, WC-0 andWD-1; Figure 1).
Eighty-two DGGE bands, the intensity of which varied
over the supplementation period compared to t = 0, were
assigned to bacterial types after DNA isolation, re-ampliﬁcation,
sequencing, and sequence comparison. The most common
microbial types that responded to the presence of isoﬂavones
were Bifidobacterium adolescentis, Faecalibacterium prausnitzii,
Lactonifactor longoviformis, Flavonifractor plautii, Coprococcus
sp., Blautia sp., Oribacterium sp., Ruminococcus sp., and
members of the family Lachnospiraceae. However, the DGGE
proﬁles from equol-producer women did not cluster together,
and an apparent association between equol production and
presence of speciﬁc bands was not observed.
Since the universal prokaryotic primers showed all
biﬁdobacterial populations to increase over the supplementation
period, DGGE analyses were performed using biﬁdobacteria-
speciﬁc primers. Compared to the complex DGGE proﬁles
for total bacteria, the biﬁdobacterial proﬁles were rather
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TABLE 3 | Viable counts of total and indicator fecal microbial populations in menopausal women treated with a soy isoflavone supplement over a
6-month period.
Equol Month Microbial countsa
MCB MRSC BIF RCM EMB BP VA
Producers (n = 4) 0 9.51 ± 1.12 9.29 ± 1.39 9.44 ± 1.11 9.21 ± 1.31 7.69 ± 1.19 9.87 ± 1.27 9.65 ± 1.35
1 10.46 ± 0.68 10.55 ± 0.82 10.28 ± 0.75 9.79 ± 1.92 8.91 ± 1.53 11.16 ± 0.63 10.65 ± 0.29
3 10.73 ± 0.75 10.37 ± 0.83 10.49 ± 0.95 10.27 ± 0.52 7.35 ± 1.01 10.87 ± 0.87 10.42 ± 0.60
6 9.79 ± 0.25 8.96 ± 0.87 9.53 ± 0.19 9.32 ± 0.40 7.17 ± 0.57 10.08 ± 0.13 9.36 ± 0.22
Non-producers (n = 12) 0 10.32 ± 0.61 10.04 ± 0.81 10.21 ± 0.67 10.23 ± 0.70 8.01 ± 0.98 10.45 ± 0.60 10.16 ± 0.73
1 10.42 ± 0.81 10.06 ± 1.00 10.30 ± 0.82 10.38 ± 0.87 7.82 ± 0.70 10.80 ± 0.71 10.64 ± 0.75
3 9.75 ± 0.76 9.30 ± 1.15 9.65 ± 0.69 9.49 ± 0.92 7.32 ± 1.07∗ 10.13 ± 0.62 9.23 ± 0.85
6 9.54 ± 0.54∗∗ 9.10 ± 0.72∗∗ 9.47 ± 0.49∗∗ 9.19 ± 0.68∗∗ 7.31 ± 1.03∗ 9.74 ± 0.57∗∗ 8.86 ± 0.75∗∗∗
aLog10 cfu g−1 of feces (mean ± SD).
Key of media (target population): MCB, Medium for Colon Bacteria (total cultivable bacteria); MRSC; de Man, Rogosa, and Sharpe (lactobacilli); BIF, BCCMTM/LMG-
Medium M144 (bifidobacteria); RCM, Reinforced Clostridium Medium (clostridia); EMB, Eosin Methylene Blue (enterobacterias); BP, Bacteroides and Prevotella medium
(Bacteroides and Prevotella sp.); VA, Veillonella Agar (Veillonella sp.).
Key of statistical significance respect to basal time (t = 0): ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001.
simple, involving just 2–5 bands per subject (partial results
are provided in Supplementary Figure S2). In contrast to the
general proﬁles, the biﬁdobacterial proﬁles for most of the
women proved stable throughout the supplementation period.
In total, 18 bands were isolated from the DGGE gels and
identiﬁed as before. B. bifidum, B. longum, B. catenulatum/B.
pseudocatenulatum, and B. adolescentis were the most common
biﬁdobacterial species identiﬁed. Other species, such as
B. saeculare and B. ruminantium, were occasionally identiﬁed.
In two of the women (WB and WG), the bands corresponding
to B. adolescentis increased markedly over the supplementation
period.
qPCR Analysis
qPCR detected wide variations in bacterial population sizes
among subjects, and between samples from the same subject
at diﬀerent sampling points (Supplementary Table S3).
The majority populations were formed by Bacteroides and
Clostridium. Biﬁdobacteria and lactobacilli made up <10
and <0.5%, respectively, of total bacterial numbers. Over the
supplementation period, opposite trends were seen between
the equol producers and non-producers in terms of the
change in some other bacterial populations. For example,
biﬁdobacterial populations decreased in size in the equol
producers, but increased in the non-producers, while the
population of Bacteroides increase in equol producers and
decrease in the non-producers (Table 4). The population of
enterobacterias was shown to be signiﬁcantly lower in equol
producers than in non-producers. In this last group of women,
increased numbers of enterobacteria were seen at t = 3 and
t = 6 (Table 4). The two Clostridium clusters (leptum and
coccoides) targeted by speciﬁc primers were seen to increase
in the equol producers, especially at t = 3 and t = 6, while
their numbers remained similar in samples from the non-
producers. Finally, the Atopobium population increased over
the supplementation period in both groups of women, but more
so in the non-producers (a signiﬁcant increase was detected
at t = 3).
Discussion
The metabolism of soy isoﬂavones, and therefore their
bioavailability and activity in humans, strongly depends on
the activity of the intestinal microbiota. The underlying
interactions between microbial populations and isoﬂavone
metabolites, however, remain poorly understood (Frankenfeld,
2011; Clavel and Mapesa, 2013).
Though several methods have been proposed to determine
human equol production phenotype (Rowland et al., 2000;
Setchell and Cole, 2006), the cut-oﬀ for the assignment of
producer or non-producer status remains rather arbitrary. In
the present work, producers and non-producers were identiﬁed
based on a cut-oﬀ of 1000 nM equol in urine, as deﬁned by
Rowland et al. (2000). The same number of equol producers
and non-producers were also obtained when considering an
equol/creatinine ratio >5 as the cut-oﬀ (Rowland et al., 2000).
The frequency of equol producers diﬀer widely among human
communities (Setchell et al., 2002). That reported in the present
work agrees well with values reported by other authors for
Western women (Atkinson et al., 2005; Setchell and Cole, 2006;
Possemiers et al., 2007; Frankenfeld, 2011; Nakatsu et al., 2014).
In contrast to that reported by Franke et al. (2012), equol
production phenotype proved to be stable over the study period;
no conversion from equol producer to non-producer or vice versa
was observed.
The eﬀects of isoﬂavones on the gut microbiota have been
little examined (Clavel et al., 2005; Bolca et al., 2007; Nakatsu
et al., 2014), and with the exception of the study by Clavel
et al. (2005), which lasted two months, changes in bacterial
populations have only ever been monitored over short periods.
Further, apart from the work of Nakatsu et al. (2014), which
involved phylogenetic/metagenomic analyses, the number of
populations targeted has been very limited. In the present work,
the eﬀects of isoﬂavones on the fecal microbiota of healthy
menopausal women were analyzed at 1, 3, and 6 months of
supplementation, and the results compared to those at baseline.
This design, however, may have overlooked signiﬁcant changes
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FIGURE 1 | Denaturing gradient gel electrophoresis (DGGE) profiles
of the total microbial populations from fecal samples of
menopausal women at different times during isoflavone treatment
using universal prokaryotic primers amplifying the V2-V4
hypervariable regions of the 16S rRNA gene. Similarity of the profiles
was calculated by the Dice’s coefficient and clustered by the UPGMA
method. Position of the profiles from equol producer women is indicated
by a doted box.
Frontiers in Microbiology | www.frontiersin.org 7 August 2015 | Volume 6 | Article 777
Guadamuro et al. Isoflavones, equol, and fecal microbial populations
TABLE 4 | Relative quantities of fecal microbial populations in the different equol status groups of the menopausal women treated with soy isoflavones
of this study as determined by qPCR using universal and group-specific primers.
Equol status Month Microbial populationa
Bifidobacteria Lactobacilli Clostridium
leptum
Clostridium
coccoides
Bacteroides Enterobacteria Atopobium
Producers
(n = 4)
0 3.47 ± 5.74a 0.51 ± 0.91 28.70 ± 7.67 23.36 ± 14.31 73.6 ± 126.20 0.008 ± 0.001 4.87 ± 3.35
1 1.00 ± 0.80 < 0.01 ± 0.01 19.64 ± 8.25 24.19 ± 18.58 104.9 ± 181.7 0.003 ± 0.004 5.64 ± 2.15
3 2.05 ± 1.37 0.13 ± 0.20 35.69 ± 13.52 40.34 ± 24.18 45.31 ± 59.72 < 0.001 ± 0.001 5.96 ± 1.00
6 1.43 ± 1.04 0.04 ± 0.03 33.14 ± 13.25 32.43 ± 24.08 113.3 ± 210.1 0.004 ± 0.006 4.70 ± 1.72
Non-producers
(n = 12)
0 4.96 ± 6.19 0.31 ± 0.81 23.89 ± 8.75 25.33 ± 16.51 29.08 ± 63.03 0.20 ± 0.52 3.77 ± 1.97
1 7.63 ± 7.87 0.31 ± 0.89 26.17 ± 17.11 26.97 ± 18.59 20.57 ± 31.07 0.14 ± 0.27 5.61 ± 4.25
3 6.84 ± 9.17 0.05 ± 0.07 24.72 ± 10.89 25.15 ± 16.60 15.53 ± 14.42 0.83 ± 0.22 6.24 ± 4.90∗
6 9.27 ± 13.11 0.35 ± 0.68 19.98 ± 10.13 24.26 ± 16.80 12.55 ± 9.46 0.49 ± 0.13 4.85 ± 2.88
aPercentage of the total bacterial 16S rDNA (mean ± SD), as determined using the universal prokaryotic primers TBA-F and TBA-R (Table 1).
Key of statistical significance: ∗p < 0.05 versus basal sample (t = 0).
occurring soon after the start of isoﬂavone supplementation
(Bolca et al., 2007; Nakatsu et al., 2014).
In general, the community structure and composition of
the fecal bacterial populations changed signiﬁcantly with the
isoﬂavone supplementation. However, wide inter- and intra-
individual (at diﬀerent times) variations were detected by
the diﬀerent techniques employed, making it very diﬃcult to
correlate isoﬂavone intake with any changes in the bacterial
community structure/population size, or changes in the latter
with equol production. Thus, not surprisingly, PCoA of culturing
and qPCR results showed no association between microbial
communities and equol production status (Supplementary Figure
S3). It is conceivable that isoﬂavones directly or indirectly
aﬀect members of the dominant microbiota (Clavel and
Mapesa, 2013). In addition to the selective pressure they
may exert on isoﬂavone-utilizing microorganisms, isoﬂavones
or their metabolites (aglycones, equol, O-DMA, etc.) might
modify conditions in the intestinal tract with an ensuing eﬀect
on susceptible bacterial communities. A biﬁdogenic eﬀect of
isoﬂavones has been reported in some studies (Clavel et al.,
2005; Nakatsu et al., 2014), and a modest eﬀect of this kind
for most of the samples at t = 1 was conﬁrmed by culturing.
However, it did not persist through to t = 3 and t = 6. In
equol producers, increases in population size within Clostridium
clusters have been observed before (Clavel et al., 2005; Possemiers
et al., 2007). However, such stimulatory eﬀects may depend
on the baseline sizes of these populations, which can vary
widely between subjects. In contrast, a reduction was seen
in the number of enterobacterias in the samples from most
women (Supplementary Table S2). Since several members of the
Enterobacteriaceae, including Escherichia coli phylotypes, harbor
a ∼54 kb polyketide synthase (pks) pathogenicity island that
encodes multi-enzymatic machinery for synthesizing a genotoxin
that promotes tumorigenesis (Arthur et al., 2012), a fall in their
numbers might be beneﬁcial. However, no changes in the fecal
microbial populations that were convincingly supplementation-
speciﬁc were seen, suggesting that (at least some) changes might
be due to normal variations caused by diet or other uncontrolled
environmental factors. Together, the present enumeration results
suggest that the consumption of isoﬂavones induces changes in
the majority of microbial populations in both equol producers
and non-producers, although these might be opposite.
The inadequacy of conventional culturing techniques for
reﬂecting the microbial diversity of the intestinal ecosystem
(Leser et al., 2002; Kemperman et al., 2010; Li et al., 2014)
prompted the use of two culture-independent methods: DGGE
for proﬁling the majority microbial species, and qPCR for
targeting speciﬁc microbial populations. In some woman,
speciﬁc bands corresponding to microorganisms previously
associated with the metabolism of isoﬂavones and other dietary
phytoestrogens (L. longoviformis, F. prausnitzii, Bifidobacterium
sp., Ruminococcus sp.; Bolca et al., 2007; Clavel et al., 2007;
Nakatsu et al., 2014) were enhanced in intensity. As suggested
by Nakatsu et al. (2014), such increases may argue for
isoﬂavones providing a chemical environment that selects for a
subset of the initial bacterial community (Clavel and Mapesa,
2013). Alternatively, isoﬂavones might have antimicrobial eﬀects
on certain bacterial populations, as reported for ﬂavonoid
compounds (Orhan et al., 2010). In either case, the UPGMA
analysis grouped the DGGE proﬁles by individual rather than by
treatment (isoﬂavones, non-isoﬂavones), suggesting the changes
detected by this technique depend on the initial microbial
proﬁle (personal microbiota). Furthermore, DGGE only detects
changes occurring within the dominant bacterial populations
(Muyzer et al., 1993); subtle changes in subdominant or minority
species also occur but go unseen, and equol production might
result from interactions between dominant and subdominant
(or even minority) intestinal populations. In contrast, qPCR
involving universal and group-speciﬁc primers produces a
general microbial picture similar to that produced by state-of-
the-art metagenomic techniques (Qin et al., 2010; Li et al., 2014).
Discrepancies between culturing and culture-independent
methods may result from diﬀerences in lysis eﬃciency during
DNA isolation, preferential PCR ampliﬁcation (which may be
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diﬀerent for each primer pair), or interspecies diﬀerences in
16S rRNA operon copy number (Kemperman et al., 2010).
The detection of non-cultivatable and dead cells by DNA-based
techniques may account for further diﬀerences. In this sense,
low recoveries of Bacteroidetes from frozen fecal samples have
been reported (Bahl et al., 2012). However, in the present work
Bacteroides sp. proved to be majority population in both equol
producers and non-producers.
Conclusion
Both the culturing and the culture-independent methods
used in this work detected wide microbial diversity in the
studied menopausal women at baseline. Variations in the
microbial communities over the six-month period of isoﬂavone
supplementation were also large. No general patters of
change due to isoﬂavone ingestion, or associated with equol
production, were observed. The production of equol could
not be correlated to the presence of, or increase in, any of
the bacterial populations analyzed. This suggests isoﬂavone
metabolism may diﬀer in diﬀerent people depending on their
personal gut microbiota. Metagenomics, metabolomics, and
metatranscriptomics analyses will be required to uncover
the relationships between the structure and composition
of the intestinal microbial communities in response to
soy isoﬂavones and their metabolic compounds. Further
research in this area could ultimately lead to the modulation
of numbers of equol-producing bacteria, and thus equol
producer-status, through the use of speciﬁc prebiotics and/or
probiotics.
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